These exosomes efficiently transported bioactive components to the cortex and hippocampus and led to a reduction in amyloid plaque deposition, beta-amyloid levels and inflammation in transgenic mice (human amyloid precursor protein(APP)/presenilin 1 (PS1)) [81]. Here, APP is linked to amyloidosis.